| Core# No. | Age | Sex | Organ | Diagnosis | pTNM | Stage | Tissuetype | Image |
| 1 | 65 | F | Ovary | serous papillary cystadenoma of borderline malignancy | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 2 | 26 | F | Ovary | mucinous cystadenoma of borderline malignancy | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 3 | 35 | F | Ovary | serous papillary cystadenoma of borderline malignancy | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 4 | 65 | F | Ovary | serous cystadenocarcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 5 | 48 | F | Ovary | endometrioid carcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 6 | 44 | F | Ovary | granulosa cell tumor | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 7 | 49 | F | Ovary | endometrioid carcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 8 | 67 | F | Ovary | mucinous cystadenoma of borderline malignancy | T2bN0M0 | IIB | 5 | " class="fd_image"> |
|
| 9 | 75 | F | Ovary | serous cystadenofibroma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 10 | 50 | F | Ovary | papillary serous cystadenocarcinoma, poorly differentiated | T2cN0M0 | IIC | 6 | " class="fd_image"> |
|
| 11 | 44 | F | Ovary | fibroma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 12 | 50 | F | Ovary | papillary serous cystadenocarcinoma | T3cN0M1 | IV | 6 | " class="fd_image"> |
|
| 13 | 47 | F | Ovary | endometrioid carcinoma | T3cN0M1 | IV | 6 | " class="fd_image"> |
|
| 14 | 38 | F | Ovary | mixed Brenner tumor and mucinous cystadenoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 15 | 58 | F | Ovary | papillary serous cystadenocarcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 16 | 70 | F | Ovary | papillary serous cystadenocarcinoma | T3bN0M0 | IIIB | 6 | " class="fd_image"> |
|
| 17 | 65 | F | Ovary | struma ovarii | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 18 | 79 | F | Ovary | endometrioid adenoacanthofibroma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 19 | 57 | F | Ovary | serous surface papillary carcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 20 | 43 | F | Ovary | papillary serous cystadenocarcinoma | T3bN0M0 | IIIB | 6 | " class="fd_image"> |
|
| 21 | 68 | F | Ovary | undifferentiated carcinoma | T1bN0M0 | I B | 6 | " class="fd_image"> |
|
| 22 | 50 | F | Ovary | clear cell carcinoma | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 23 | 23 | F | Ovary | dysgerminoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 24 | 51 | F | Ovary | common epithelial carcinoma, poorly differentiated | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 25 | 70 | F | Ovary | malignant muellerian mixed tumor | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 26 | 21 | F | Ovary | dysgerminoma | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 27 | 34 | F | Ovary | fibrothecoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 28 | 61 | F | Ovary | papillary serous cystadenocarcinoma | T3bN0M0 | IIIB | 6 | " class="fd_image"> |
|
| 29 | 54 | F | Ovary | sertoli-leydig cell tumor | T1bN0M0 | IB | 4 | " class="fd_image"> |
|
| 30 | 53 | F | Ovary | fibrothecoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 31 | 54 | F | Ovary | fibrothecoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 32 | 34 | F | Ovary | papillary serous cystadenocarcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 33 | 31 | F | Ovary | dysgerminoma | T2cN0M0 | IIC | 6 | " class="fd_image"> |
|
| 34 | 51 | F | Ovary | papillary serous cystadenocarcinoma | T2bN1M0 | IIIC | 6 | " class="fd_image"> |
|
| 35 | 61 | F | Ovary | granulosa-theca cell tumor | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 36 | 24 | F | Ovary | sertoli-leydig cell tumor | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 37 | 27 | F | Ovary | sclerosing stromal tumor | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 38 | 41 | F | Ovary | clear cell carcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 39 | 56 | F | Ovary | malignant muellerian mixed tumor | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 40 | 41 | F | Ovary | clear cell carcinoma | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 41 | 27 | F | Ovary | embryonal carcinoma | T2aN0M0 | II A | 6 | " class="fd_image"> |
|
| 42 | 55 | F | Ovary | granulosa cell tumor | T1aN0M0 | I A | 5 | " class="fd_image"> |
|
| 43 | 23 | F | Ovary | dysgerminoma | T1aN0M0 | I A | 6 | " class="fd_image"> |
|
| 44 | 64 | F | Ovary | papillary serous cystadenocarcinoma | T2cN1M0 | IIIC | 5 | " class="fd_image"> |
|
| 45 | 43 | F | Ovary | metastatic adenocarcinoma (most likely from breast) | M1 | IV | 6 | " class="fd_image"> |
|
| 46 | 48 | F | Ovary | malignant lymphoma | . | II | 6 | " class="fd_image"> |
|
| 47 | 50 | F | Ovary | adenocarcinoma from salpinx | T2bN0M0 | IIB | 6 | " class="fd_image"> |
|
| 48 | 25 | F | Ovary | fibrothecoma | T1aN0M0 | IA | 4 | " class="fd_image"> |
|
| 49 | 46 | F | Ovary | metastatic undifferentiated carcinoma | M1 | IV | 6 | " class="fd_image"> |
|
| 50 | 37 | F | Ovary | metastatic signet ring carcinoma from stomach | M1 | IV | 6 | " class="fd_image"> |
|
| 51 | 55 | F | Ovary | serous cystadenocarcinoma, moderatelydifferentiated | T3bN0M0 | IIIB | 6 | " class="fd_image"> |
|
| 52 | 55 | F | Ovary | fibrothecoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
|
| 53 | 45 | F | Ovary | serous cystadenocarcinoma, moderatelydifferentiated | T2cN0M0 | IIC | 6 | " class="fd_image"> |
|
| 54 | 37 | F | Ovary | endometrioid carcinoma | T2bN0M0 | IIB | 6 | " class="fd_image"> |
| 55 | 58 | F | Ovary | fibrothecoma | T1aN0M0 | I A | 4 | " class="fd_image"> |
| 56 | 65 | F | Ovary | adenocarcinoma, poorly differentiated | T3cN0M0 | IIIC | 6 | " class="fd_image"> |
| 57 | 39 | F | Ovary | clear cell carcinoma | T2cN1M0 | IIIC | 6 | " class="fd_image"> |
| 58 | 70 | F | Ovary | fibroma | T1aN0M0 | I A | 4 | " class="fd_image"> |
| 59 | 58 | F | Ovary | clear cell carcinoma | T1aN0M0 | I A | 6 | " class="fd_image"> |
| 60 | . | . | Carbon | . | . | . | . | " alt="" class="fd_image"> |
